NO146777C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater

Info

Publication number
NO146777C
NO146777C NO77771263A NO771263A NO146777C NO 146777 C NO146777 C NO 146777C NO 77771263 A NO77771263 A NO 77771263A NO 771263 A NO771263 A NO 771263A NO 146777 C NO146777 C NO 146777C
Authority
NO
Norway
Prior art keywords
ingrediates
naphyridine
indolo
preparation
therapeutic active
Prior art date
Application number
NO77771263A
Other languages
English (en)
Norwegian (no)
Other versions
NO771263L (no
NO146777B (no
Inventor
Gabor Istvan Koletar
Henry Najer
Jean-Pierre Gaston Lefevre
Regis Dupont
Don Pierre Rene Luc Giudicelli
Claude Constant Henri Morel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7610773A external-priority patent/FR2358146A1/fr
Priority claimed from FR7616445A external-priority patent/FR2353550A2/fr
Priority claimed from FR7632319A external-priority patent/FR2368955A2/fr
Priority claimed from FR7639035A external-priority patent/FR2374905A2/fr
Priority claimed from FR7707248A external-priority patent/FR2383181A2/fr
Priority claimed from FR7707249A external-priority patent/FR2383182A2/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO771263L publication Critical patent/NO771263L/no
Publication of NO146777B publication Critical patent/NO146777B/no
Publication of NO146777C publication Critical patent/NO146777C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO77771263A 1976-04-13 1977-04-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater NO146777C (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR7610773A FR2358146A1 (fr) 1976-04-13 1976-04-13 Derives de la tetrahydro-1,2,3,3a indolo(3,2,1-de) (1,5)naphtyridine
FR7616445A FR2353550A2 (fr) 1976-06-01 1976-06-01 Procede de preparation de derives de naphtyridine
FR7632319A FR2368955A2 (fr) 1976-10-27 1976-10-27 Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine
FR7639035A FR2374905A2 (fr) 1976-12-24 1976-12-24 Derives de naphtyridine
FR7707248A FR2383181A2 (fr) 1977-03-11 1977-03-11 Derives de naphtyridine
FR7707249A FR2383182A2 (fr) 1977-03-11 1977-03-11 Nouveaux derives de naphtyridine

Publications (3)

Publication Number Publication Date
NO771263L NO771263L (no) 1977-10-14
NO146777B NO146777B (no) 1982-08-30
NO146777C true NO146777C (no) 1982-12-08

Family

ID=27546337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO77771263A NO146777C (no) 1976-04-13 1977-04-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater

Country Status (24)

Country Link
US (1) US4190657A (pt)
JP (1) JPS5823877B2 (pt)
AR (1) AR214519A1 (pt)
AU (1) AU506031B2 (pt)
CA (1) CA1072960A (pt)
CH (1) CH622795A5 (pt)
DD (1) DD129791A5 (pt)
DE (1) DE2716190A1 (pt)
DK (1) DK143703C (pt)
FI (1) FI63404C (pt)
GB (1) GB1543283A (pt)
GR (1) GR63658B (pt)
IE (1) IE44989B1 (pt)
IL (1) IL51853A (pt)
LU (1) LU77100A1 (pt)
MT (1) MTP811B (pt)
MX (1) MX5340E (pt)
NO (1) NO146777C (pt)
NZ (1) NZ183846A (pt)
PL (1) PL197373A1 (pt)
PT (1) PT66428B (pt)
SE (2) SE432932B (pt)
SU (1) SU655314A3 (pt)
YU (1) YU94877A (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5337696A (en) * 1976-08-26 1978-04-06 Omnium Chimique Sa Hexahydrocantinonee6 derivative
US4228168A (en) * 1978-11-22 1980-10-14 Tanabe Seiyaku Co., Ltd. Azepino [1,2,3-lm]-β-carboline compounds and pharmaceutical composition thereof
US4367230A (en) * 1980-01-04 1983-01-04 Tanabe Seiyaku Co., Ltd. Novel triazafluoranthene compound and processes for preparing the same
FR2494693A1 (fr) * 1980-11-21 1982-05-28 Synthelabo Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique
FR2517679A1 (fr) * 1981-12-03 1983-06-10 Synthelabo Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique
LU84664A1 (fr) * 1983-02-25 1984-11-08 Onmichem S A Alkyl-4-indolonaphtyridines et leur application therapeutique
EP0347980A1 (en) * 1988-06-20 1989-12-27 Duphar International Research B.V 8,9-Annelated beta-carbolines and 8,9-anelated-3,4-dihydro-beta-carbolines
CN103193776A (zh) * 2013-04-16 2013-07-10 苏州维泰生物技术有限公司 一种具有抗肿瘤疗效的新型萘啶衍生物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299078A (en) * 1962-10-01 1967-01-17 Smith Kline French Lab Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
US3555018A (en) * 1968-12-03 1971-01-12 Ayerst Mckenna & Harrison Thiazinopyridoindolone derivatives

Also Published As

Publication number Publication date
SU655314A3 (ru) 1979-03-30
PT66428A (fr) 1977-05-01
SE7704172L (sv) 1977-10-14
YU94877A (en) 1983-01-21
AR214519A1 (es) 1979-06-29
IE44989B1 (en) 1982-06-02
NZ183846A (en) 1980-09-12
DK161377A (da) 1977-10-14
NO771263L (no) 1977-10-14
SE432932B (sv) 1984-04-30
FI63404C (fi) 1983-06-10
CH622795A5 (pt) 1981-04-30
DE2716190A1 (de) 1977-10-27
MX5340E (es) 1983-06-27
LU77100A1 (pt) 1979-01-18
FI771159A (pt) 1977-10-14
DK143703C (da) 1982-04-13
SE8201181L (sv) 1982-05-25
IL51853A0 (en) 1977-06-30
CA1072960A (en) 1980-03-04
IL51853A (en) 1979-11-30
JPS52125198A (en) 1977-10-20
US4190657A (en) 1980-02-26
JPS5823877B2 (ja) 1983-05-18
FI63404B (fi) 1983-02-28
DD129791A5 (de) 1978-02-08
GR63658B (en) 1979-11-28
MTP811B (en) 1978-02-20
PL197373A1 (pl) 1978-02-13
NO146777B (no) 1982-08-30
PT66428B (fr) 1978-09-20
IE44989L (en) 1977-10-13
AU2418977A (en) 1978-10-19
AU506031B2 (en) 1979-12-13
GB1543283A (en) 1979-04-04
DK143703B (da) 1981-09-28

Similar Documents

Publication Publication Date Title
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO149586C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider
NO156752B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO147913C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO145198C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3
NO152414C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO146777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO145163C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.